Autoantibodies are highly prevalent in non-SARS-CoV-2 respiratory infections and critical illness.
JCI Insight
; 8(3)2023 02 08.
Article
in En
| MEDLINE
| ID: mdl-36752204
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Autoantibodies
/
COVID-19
Type of study:
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
JCI Insight
Year:
2023
Document type:
Article